NEW YORK (GenomeWeb News) – A European consortium plans to catalog and eventually produce all binding molecules that can help detect and identify human proteins.
 
“The objective is to set the basis for an infrastructure of binding molecules against the human proteome for detection, validation, and functional studies of the human proteome,” according to Michael Taussig, head of technology research at the Babraham Institute in Cambridge, UK, the coordinating partner of the consortium, called ProteomeBinders.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.